As per the estimates of Kotak Institutional Equities the company#39;s US business may increase $20 million quarter-on-quarter (QoQ) led by Ciprodex and other recent launches.from Moneycontrol Latest News https://ift.tt/3oC0kFU
As per the estimates of Kotak Institutional Equities the company#39;s US business may increase $20 million quarter-on-quarter (QoQ) led by Ciprodex and other recent launches.
Post a Comment
Post a Comment
please do not enter spam link in the comment box